Sexual Identity and Bullying

Tools

Story Updated: Feb 5, 2013

..it's not always the "best days" of their lives. But it can be especially challenging for gay, lesbian and bisexual teens.

So researchers wanted to know if it gets better for this group after high school. Using data collected from more than 4-thousand teens between 2004 and 2010, the team looked at how rates of bullying changed as the teens got older, and what effect bullying has on their emotions.

Compared to their heterosexual peers, LGB boys and girls were about twice as likely to be bullied throughout high school. But generally...the bullying for girls declined significantly as they left high school. 57 percent of lesbian or bisexual girls reported being bullied at age 13 or 14, compared to 6 percent at age 19 or 20.

Among boys, the bullying declined from 52 percent in the early teen years to 9 percent at 19 or 20...BUT the likelihood of still being bullied actually increased after high school when compared to straight boys. LGB males and females had significantly higher levels of emotional distress than their heterosexual-identified peers.

Researchers say these findings show how critical it is to address LGB victimization during adolescence.

I'm Dr. Cindy Haines of HealthDay TV with the health news for you and your family.

Add a comment

Name:

Comment: 250 Characters Left

WBNG and its affiliated companies are not responsible for the content of comments posted or for anything arising out of use of the above comments or other interaction among the users. We reserve the right to screen, refuse to post, remove or edit user-generated content at any time and for any or no reason in our absolute and sole discretion without prior notice, although we have no duty to do so or to monitor any Public Forum.

Featured Professional
Dr. Michael Fallon

Cancer Center

Lourdes Regional Cancer Center


Watch our Docs on Call Interviews:
Interviews with Dr. Roney
Interviews with Dr. Anne
Interviews with Elizabeth Sweeney
Interviews with Michael Fallon
Interviews with Joe Viscello
Interviews with Michelle Williams
Interviews with Dr. Madhuri Yalamanchili
Interviews with Dr. Sandra Haynes
Interviews with Dr. Francine Rainone
Interviews with Dr. James Kondrup
Interviews with Dr. Michael Barrett
Interviews with Dr. Madhukar Bhoomireddi
Interviews with Nurse Julann Ashman
Interviews with Nurse Mary Mancini
Interviews Dr. Rayford Petroski
Interviews Dr. Ghassem Mangouri
Interviews Azur Kelly
The LOURDES Regional Cancer Center is the area's premier facility dedicated to spiritually based, comprehensive cancer care. Since 1957, the Lourdes Regional Cancer Center has been providing the Southern Tier of New York with outstanding cancer care.

Now, nearly fifty years later, the LOURDES Regional Cancer Center continues that mission. Since 1971, the Lourdes Regional Cancer Center has been accredited as a Community Hospital Comprehensive Cancer Program. Most recently, Lourdes has been awarded the 2008 Commission on Cancer Outstanding Achievement Award by the Commission on Cancer American College of Surgeons. The Award is designed to recognize cancer programs that strive for excellence in providing quality care to cancer patients. Lourdes is one of only 95 facilities in the US to receive this award.

Today, Lourdes is among the largest and most sophisticated community cancer centers in the country. Here within the region's premier facility dedicated to the fight against cancer we've gathered the area's top physicians and oncologists. We've assembled select teams of cancer nurses and specialists and we've brought to the Southern Tier some of the newest weapons to fight cancer.

Pastoral care, nutrition services, and rehabilitation services are also available for both outpatients and inpatients. Lourdes Regional Cancer Center also maintains a link with the National Cancer Institute's (NCI) database. This database provides the latest information on research advances and new treatments, as well as emerging topics on the influence of genetics, environmental factors and lifestyle factors in the development of cancer.

For more information visit www.lourdes.com.